Inventiva will present updates related to its MASH clinical trial therapy programme at several...
Category - Pharmaceuticals
Oncolytics Biotech launches metastatic colorectal cancer study...
Oncolytics Biotech has launched a new metastatic colorectal cancer study to evaluate its...
BioNTech co-founders plan new biotech company to advance next...
BioNTech has announced plans for a new biotechnology company focused on next-generation mRNA...
Sonas Pharma closes pre-seed investment round backed by SFC...
Sonas Pharma has closed a pre-seed funding round backed by SFC Capital and Clarendon Fund Managers...
Interim Phase 2 data show functional improvement with IMM01-STEM...
Immunis has reported interim Phase 2 clinical data showing improvements in physical function among...
Novartis ianalumab receives FDA Breakthrough Therapy designation...
Novartis has received US Food and Drug Administration Breakthrough Therapy designation for...
Jasper Therapeutics reports positive briquilimab data in chronic...
Jasper Therapeutics has reported updated clinical data showing disease control in patients treated...
Breast cancer remains the world’s most-studied disease area in...
Phesi has published its latest annual analysis of global clinical development activity, based on...
Bayer receives Breakthrough Therapy Designation for sevabertinib...
Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...
Alnylam to invest $250 million in enzymatic ligation platform to...
Alnylam Pharmaceuticals has announced a $250 million investment to expand its US manufacturing...

